Topcon Due Diligence

Run due diligence on Topcon: check compliance and get alerts when suppliers change.

Japan · www.topcon.com · 18 vendors

Topcon Corporation is a Japanese manufacturer and global leader in technology, specializing in optical, sensing, and control solutions. The company develops cutting-edge products and services for healthcare, agriculture, and infrastructure, including ophthalmic instruments, surveying systems, GPS, and machine control systems. Topcon aims to solve societal challenges through digital transformation technologies.

Resilience scores

Technology vendors

Services catalogue

3 services in catalogue across 2 categories; runs on 18 sub-vendors.

Insights

Last updated 2026-08-15 · revision 2

18 direct vendors, 202 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Compliance

12 in-scope frameworks identified; showing 3.

EU Medical Device Regulation — No public evidence

Evidence: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745, https://ec.europa.eu/health/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en, https://www.topconhealthcare.com/, https://ec.europa.eu/tools/eudamed/

CPRA — No public evidence

Evidence: https://cppa.ca.gov/, https://oag.ca.gov/privacy/ccpa, https://www.topcon.com/

NIS2 (source) — No public evidence

Evidence: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022L2555, https://www.enisa.europa.eu/topics/cybersecurity-policy/nis-directive-new, https://www.topcon.com/

Financials

Three-year financials

Financial Resilience Score: 6/10

Topcon Corporation demonstrates moderate financial resilience supported by a diversified business portfolio across three end-markets (positioning/construction, smart infrastructure, and healthcare/eye-care) with limited cyclical correlation between them. The company has a solid equity base of approximately ¥130+ billion with historically manageable net debt, and benefits from global reach with the majority of sales outside Japan, providing natural yen-weakness tailwinds. Strong technology moats exist in GNSS receivers, machine-control for construction, and ophthalmic diagnostic devices, with long-standing OEM/partnership relationships. However, FY2023 exposed significant earnings volatility, with operating income declining approximately 47% due to inventory adjustments in the U.S. agriculture/construction dealer channel amid higher interest rates. Operating margin has historically ranged between 5% and 10%, and the company faces intense competition from Trimble, Hexagon/Leica in positioning, and Zeiss, Nidek, Canon in ophthalmology. High R&D intensity is required to defend positions, and there is notable exposure to the U.S. interest-rate cycle via financed equipment sales. Take-private speculation by KKR and JIP in 2024 suggests the market views margins as under-optimized.

Key strengths: Diversified portfolio across three end-markets with limited cyclical correlation, Global reach with majority of sales outside Japan, Strong technology moats in GNSS, machine-control, and ophthalmic devices, Long-standing OEM/partnership relationships, Solid equity base (~¥130+ bn) with manageable net debt

Risk factors: Earnings volatility as demonstrated by FY2023 operating margin compression, Exposure to U.S. interest-rate cycle via financed equipment sales, FX exposure (USD, EUR), Intense competition from Trimble, Hexagon/Leica, Zeiss, Nidek, Canon, High R&D intensity required to maintain competitive positions, Governance/activist pressure and take-private discussions

Revenue by geography

Revenue by product/service

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report